Study to Evaluate DACC Dressings for the Prevention of Surgical Site Infections in Women Undergoing Caesarean Section.
Surgical Site Infection, Infection; Cesarean Section
About this trial
This is an interventional prevention trial for Surgical Site Infection focused on measuring surgical site infection, dialkylcarbamoylchloride impregnated dressing, caesarean section, wound dehiscence
Eligibility Criteria
Inclusion Criteria:
- age ≥ 18 years
- undergoing elective or emergency caesarean section
- transverse skin incision
- low transverse uterine incision
- single and multiple pregnancy
- intravenous administration of 1g cefazolin 0-30 minutes prior to the start of surgery
- irrigation of the wound with octenidine prior to the subcutaneous tissue closure
Exclusion Criteria:
- patients age <18 years
- patients physical or mental incapacity to give informed consent
- skin incision other than transverse
- uterine incision other than low transverse
- patients that did not receive routine prophylactic dose of antibiotics prior to the start of surgery
- patients without irrigation of the wound with octenidine prior to the subcutaneous tissue closure
Sites / Locations
- Chair and Department of Obstetrics and Gynecology, II Faculty of Medicine, Medical University of Warsaw
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
DACC impregnated dressing
Standard surgical dressing
Patients undergoing elective or emergency caesarean section with DACC impregnated dressing Sorbact Surgical Dressing ® (ABIGO Medical AB, Sweden) placed over post-caesarean wound after skin closure, the dressing will be removed after the first 48 hours postoperatively
Patients undergoing elective or emergency caesarean section with standard surgical dressing placed over post-caesarean wound after skin closure, the dressing will be removed after the first 48 hours postoperatively